Earlier this year, Olympus announced its plans to reorganize the Scientific Solutions Division into a self-sustainable company. This reorganization will enable the Scientific Solutions business a greater level of autonomy and agility to respond more quickly and with more flexibility to our industrial and life science customers’ needs. Today, we are proud to inform you [...]

Shimadzu Corporation and Kobe University have started verifying the utility of a prototype autonomous laboratory system based on using robotic, digital, AI, and other technologies. The intention is to develop an autonomous laboratory system that is actually used in society, such as for developing biotechnology, pharmaceuticals, or new materials. Shimadzu Corporation has been jointly researching [...]

The Eppendorf Research® plus single-channel pipette line-up with variable volume has been certified with an “ACT®” Environmental Impact Factor Label by the “My Green Lab®” non-profit organization. By emphasizing Accountability, Consistency, and Transparency (ACT) around manufacturing, energy and water use, packaging, and end-of-life, the ACT label makes it easier for labs to choose more sustainable [...]

HANGZHOU, China -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distributor and service provider for PBI's PCT Sample Preparation System Platform and related products in China, a move that enables Westlake [...]

Company: Olympus Corporation Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi (Code: 7733, First Section, Tokyo Stock Exchange) Contact: Takaaki Sakurai, Vice President, Investor Relations Olympus Corporation ("Olympus") hereby announces that our board of directors has resolved at a meeting held today to transfer our scientific solutions business through an absorption-type company split (the [...]

Company: Olympus Corporation Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi (Code: 7733, First Section, Tokyo Stock Exchange) Contact: Takaaki Sakurai, Vice President, Investor Relations Olympus Corporation ("Olympus") hereby announces that our board of directors has resolved at a meeting held today to transfer our scientific solutions business through an absorption-type company split (the [...]

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. A powerful technology, widely used in genome science, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9 is a simple and efficient editing tool which allows for specific genome disruption and replacement facilitating the manipulation of [...]

The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. -- Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A [...]

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTG’s Therapeutics Scientific Advisory Board. Dr. Radich adds to the company’s [...]

Nicoya’s Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) KITCHENER, Ontario--Nicoya Lifesciences, a global leader in digital proteomics solutions, today announced a $20 million Series A extension led by Whitecap Venture Partners. The round included participation from strategic investor Agilent Technologies, a leading global [...]